• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼可霉素Z单独及与多烯类、三唑类或棘白菌素类联合对烟曲霉的体外活性。

In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus.

作者信息

Ganesan L T, Manavathu E K, Cutright J L, Alangaden G J, Chandrasekar P H

机构信息

Division of Infectious Diseases, Department of Medicine, Wayne State University, Detroit, MI 48201, USA.

出版信息

Clin Microbiol Infect. 2004 Nov;10(11):961-6. doi: 10.1111/j.1469-0691.2004.00996.x.

DOI:10.1111/j.1469-0691.2004.00996.x
PMID:15521997
Abstract

The in-vitro activity of nikkomycin Z was investigated in combination with polyenes, triazoles or echinocandins against 20 clinical isolates of Aspergillus fumigatus with the fractional inhibitory concentration index (FICI) method. The drug interactions were classified as synergic (FICI < or = 0.5), no interaction (FICI > 0.5, but FICI < or = 4) or antagonistic (FICI > 4). The fungicidal activity of nikkomycin Z alone and in combination with a representative echinocandin (caspofungin) or triazole (voriconazole) was also examined with time-kill experiments and fungal cell viability assays. Two-drug combinations of nikkomycin Z with amphotericin B (FICI 3.59 +/- 0.57), amphotericin B lipid complex (FICI 3.95 +/- 0.74), liposomal amphotericin B (FICI 3.62 +/- 0.98), itraconazole (FICI 2.0 +/- 0.0), voriconazole (FICI 1.07 +/- 0.37), posaconazole (FICI 2.20 +/- 0.44) or ravuconazole (FICI 1.76 +/- 0.44) showed no interactions, but the pairwise combination of nikkomycin Z with caspofungin (FICI 0.22 +/- 0.19) or micafungin (FICI 0.35 +/- 0.27) showed synergic activity against A. fumigatus. Time-kill studies and fungal cell viability assays showed that neither nikkomycin Z nor caspofungin alone possessed fungicidal activity against A. fumigatus, whereas a combination of these two drugs at concentrations > or = 2 mg/L (> or = 0.031 x the concentration of drug that produced no visible growth) killed germinated conidia within 24 h in a concentration-dependent manner. These data suggest that two-drug combinations of nikkomycin Z with echinocandins, but not with polyenes and triazoles, have a synergic effect against A. fumigatus.

摘要

采用部分抑制浓度指数(FICI)法,研究了尼可霉素Z与多烯类、三唑类或棘白菌素类药物联合对20株烟曲霉临床分离株的体外活性。药物相互作用分为协同作用(FICI≤0.5)、无相互作用(FICI>0.5但FICI≤4)或拮抗作用(FICI>4)。还通过时间杀菌实验和真菌细胞活力测定,检测了尼可霉素Z单独以及与代表性棘白菌素(卡泊芬净)或三唑类(伏立康唑)联合使用时的杀真菌活性。尼可霉素Z与两性霉素B(FICI 3.59±0.57)、两性霉素B脂质复合物(FICI 3.95±0.74)、脂质体两性霉素B(FICI 3.62±0.98)、伊曲康唑(FICI 2.0±0.0)、伏立康唑(FICI 1.07±0.37)、泊沙康唑(FICI 2.20±0.44)或雷夫康唑(FICI 1.76±0.44)的两药联合未显示相互作用,但尼可霉素Z与卡泊芬净(FICI 0.22±0.19)或米卡芬净(FICI 0.35±0.27)的两两联合对烟曲霉显示出协同活性。时间杀菌研究和真菌细胞活力测定表明,尼可霉素Z和卡泊芬净单独对烟曲霉均无杀真菌活性,而这两种药物浓度≥2mg/L(≥产生无可见生长的药物浓度的0.031倍)的联合用药在24小时内以浓度依赖方式杀死了萌发的分生孢子。这些数据表明,尼可霉素Z与棘白菌素类药物的两药联合,而非与多烯类和三唑类药物联合,对烟曲霉具有协同作用。

相似文献

1
In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus.尼可霉素Z单独及与多烯类、三唑类或棘白菌素类联合对烟曲霉的体外活性。
Clin Microbiol Infect. 2004 Nov;10(11):961-6. doi: 10.1111/j.1469-0691.2004.00996.x.
2
Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus.三唑类药物与棘白菌素类卡泊芬净联合使用对烟曲霉的两药联合差异活性。
J Antimicrob Chemother. 2003 Jun;51(6):1423-5. doi: 10.1093/jac/dkg242. Epub 2003 Apr 25.
3
Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.卡泊芬净、两性霉素B和唑类药物对耐伊曲康唑烟曲霉临床分离株的体外联合活性。
Antimicrob Agents Chemother. 2005 Mar;49(3):1232-5. doi: 10.1128/AAC.49.3.1232-1235.2005.
4
In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.通过美国国家临床实验室标准委员会(NCCLS)方法测定的阿尼芬净、米卡芬净(已获许可的药物)及研究性三唑类药物泊沙康唑对12052株真菌分离株的体外抗真菌活性:文献综述
Rev Iberoam Micol. 2003 Dec;20(4):121-36.
5
The strength of synergistic interaction between posaconazole and caspofungin depends on the underlying azole resistance mechanism of Aspergillus fumigatus.泊沙康唑与卡泊芬净之间协同相互作用的强度取决于烟曲霉潜在的唑类耐药机制。
Antimicrob Agents Chemother. 2015 Mar;59(3):1738-44. doi: 10.1128/AAC.04469-14. Epub 2015 Jan 12.
6
In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus.烟曲霉唑康唑耐药 CYP51A 突变株的体外联合伏立康唑和安尼拉芬净的疗效。
Diagn Microbiol Infect Dis. 2012 Jun;73(2):135-7. doi: 10.1016/j.diagmicrobio.2012.02.003.
7
Modeling the combination of amphotericin B, micafungin, and nikkomycin Z against Aspergillus fumigatus in vitro using a novel response surface paradigm.使用一种新型响应面模型体外模拟两性霉素B、米卡芬净和多氧霉素Z联合抗烟曲霉的效果。
Antimicrob Agents Chemother. 2007 May;51(5):1804-12. doi: 10.1128/AAC.01007-06. Epub 2007 Feb 26.
8
Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.两性霉素B、卡泊芬净和伏立康唑三联组合对曲霉菌的抗真菌相互作用。
J Antimicrob Chemother. 2006 Dec;58(6):1168-76. doi: 10.1093/jac/dkl392. Epub 2006 Oct 27.
9
Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus.尼可霉素Z与棘白菌素FK463联合作用于烟曲霉的协同作用、药效学及时间序列超微结构变化
Antimicrob Agents Chemother. 2001 Dec;45(12):3310-21. doi: 10.1128/AAC.45.12.3310-3321.2001.
10
Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms.对形成多细胞丝状生物膜的烟曲霉的阶段依赖性抗真菌活性。
J Antimicrob Chemother. 2008 Dec;62(6):1281-4. doi: 10.1093/jac/dkn402. Epub 2008 Sep 26.

引用本文的文献

1
Next-generation antifungal drugs: Mechanisms, efficacy, and clinical prospects.新一代抗真菌药物:作用机制、疗效及临床前景。
Acta Pharm Sin B. 2025 Aug;15(8):3852-3887. doi: 10.1016/j.apsb.2025.06.013. Epub 2025 Jun 23.
2
Adaptative survival of Aspergillus fumigatus to echinocandins arises from cell wall remodeling beyond β-1,3-glucan synthesis inhibition.烟曲霉对棘白菌素的适应性生存源于细胞壁重塑,超出了β-1,3-葡聚糖合成抑制的范围。
Nat Commun. 2024 Jul 31;15(1):6382. doi: 10.1038/s41467-024-50799-8.
3
Azorean Black Tea () Antidermatophytic and Fungicidal Properties.
亚速尔黑茶()抗皮肤真菌和杀菌特性。
Molecules. 2023 Nov 25;28(23):7775. doi: 10.3390/molecules28237775.
4
Chitin Biosynthesis in Species.物种中的几丁质生物合成
J Fungi (Basel). 2023 Jan 6;9(1):89. doi: 10.3390/jof9010089.
5
Specific Focus on Antifungal Peptides against Azole Resistant : Current Status, Challenges, and Future Perspectives.针对唑类耐药的抗真菌肽的特别关注:现状、挑战与未来展望
J Fungi (Basel). 2022 Dec 27;9(1):42. doi: 10.3390/jof9010042.
6
Novel Insights into Fungal Infections Prophylaxis and Treatment in Pediatric Patients with Cancer.儿童癌症患者真菌感染预防与治疗的新见解
Antibiotics (Basel). 2022 Sep 27;11(10):1316. doi: 10.3390/antibiotics11101316.
7
Activity and Mechanism of Action of Antifungal Peptides from Microorganisms: A Review.微生物来源的抗真菌肽的活性和作用机制:综述。
Molecules. 2021 Jun 5;26(11):3438. doi: 10.3390/molecules26113438.
8
Techniques for the Assessment of In Vitro and In Vivo Antifungal Combinations.体外和体内抗真菌联合用药评估技术
J Fungi (Basel). 2021 Feb 4;7(2):113. doi: 10.3390/jof7020113.
9
Antimicrobial Peptides: a New Frontier in Antifungal Therapy.抗菌肽:抗真菌治疗的新前沿。
mBio. 2020 Nov 3;11(6):e02123-20. doi: 10.1128/mBio.02123-20.
10
Hope on the Horizon: Novel Fungal Treatments in Development.曙光在前:正在研发的新型真菌治疗方法
Open Forum Infect Dis. 2020 Jan 12;7(2):ofaa016. doi: 10.1093/ofid/ofaa016. eCollection 2020 Feb.